JPS60190966A - 抗血栓性材料 - Google Patents
抗血栓性材料Info
- Publication number
- JPS60190966A JPS60190966A JP59047931A JP4793184A JPS60190966A JP S60190966 A JPS60190966 A JP S60190966A JP 59047931 A JP59047931 A JP 59047931A JP 4793184 A JP4793184 A JP 4793184A JP S60190966 A JPS60190966 A JP S60190966A
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- layer
- heparin
- antithrombotic
- fibronectin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims description 47
- 230000002785 anti-thrombosis Effects 0.000 title claims description 30
- 239000003146 anticoagulant agent Substances 0.000 title claims description 14
- 102000008186 Collagen Human genes 0.000 claims description 36
- 108010035532 Collagen Proteins 0.000 claims description 36
- 229920001436 collagen Polymers 0.000 claims description 36
- 229920000669 heparin Polymers 0.000 claims description 23
- 229960002897 heparin Drugs 0.000 claims description 22
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 16
- 102000016359 Fibronectins Human genes 0.000 claims description 12
- 108010067306 Fibronectins Proteins 0.000 claims description 12
- 239000010410 layer Substances 0.000 description 33
- 238000000034 method Methods 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 12
- 239000002861 polymer material Substances 0.000 description 12
- 239000002473 artificial blood Substances 0.000 description 10
- 210000004204 blood vessel Anatomy 0.000 description 9
- 208000028659 discharge Diseases 0.000 description 8
- -1 for example Substances 0.000 description 8
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 6
- 239000002131 composite material Substances 0.000 description 6
- 239000002504 physiological saline solution Substances 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 5
- 208000007536 Thrombosis Diseases 0.000 description 4
- 229920005601 base polymer Polymers 0.000 description 4
- 229920000728 polyester Polymers 0.000 description 4
- 238000005086 pumping Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000011248 coating agent Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000012567 medical material Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 229920001155 polypropylene Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 229920001287 Chondroitin sulfate Polymers 0.000 description 2
- 229920004934 Dacron® Polymers 0.000 description 2
- 102000009123 Fibrin Human genes 0.000 description 2
- 108010073385 Fibrin Proteins 0.000 description 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 229940059329 chondroitin sulfate Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000004132 cross linking Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229950003499 fibrin Drugs 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002635 polyurethane Polymers 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002969 artificial stone Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000021164 cell adhesion Effects 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229920000578 graft copolymer Polymers 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- 229920001477 hydrophilic polymer Polymers 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920003225 polyurethane elastomer Polymers 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 230000003381 solubilizing effect Effects 0.000 description 1
- 125000001302 tertiary amino group Chemical group 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59047931A JPS60190966A (ja) | 1984-03-13 | 1984-03-13 | 抗血栓性材料 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59047931A JPS60190966A (ja) | 1984-03-13 | 1984-03-13 | 抗血栓性材料 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60190966A true JPS60190966A (ja) | 1985-09-28 |
| JPS6158196B2 JPS6158196B2 (enrdf_load_stackoverflow) | 1986-12-10 |
Family
ID=12789112
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59047931A Granted JPS60190966A (ja) | 1984-03-13 | 1984-03-13 | 抗血栓性材料 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS60190966A (enrdf_load_stackoverflow) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
| US5028597A (en) * | 1986-04-07 | 1991-07-02 | Agency Of Industrial Science And Technology | Antithrombogenic materials |
| US5037377A (en) * | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
| JPH06173883A (ja) * | 1992-10-06 | 1994-06-21 | Toyo Denki Kogyosho:Kk | 水中ポンプ |
| US5735897A (en) * | 1993-10-19 | 1998-04-07 | Scimed Life Systems, Inc. | Intravascular stent pump |
| EP0965310A4 (en) * | 1996-12-06 | 2003-03-19 | Tapic Int Co Ltd | ARTIFICIAL BLOOD VESSEL |
-
1984
- 1984-03-13 JP JP59047931A patent/JPS60190966A/ja active Granted
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5037377A (en) * | 1984-11-28 | 1991-08-06 | Medtronic, Inc. | Means for improving biocompatibility of implants, particularly of vascular grafts |
| US4743252A (en) * | 1986-01-13 | 1988-05-10 | Corvita Corporation | Composite grafts |
| US5028597A (en) * | 1986-04-07 | 1991-07-02 | Agency Of Industrial Science And Technology | Antithrombogenic materials |
| JPH06173883A (ja) * | 1992-10-06 | 1994-06-21 | Toyo Denki Kogyosho:Kk | 水中ポンプ |
| US5735897A (en) * | 1993-10-19 | 1998-04-07 | Scimed Life Systems, Inc. | Intravascular stent pump |
| EP0965310A4 (en) * | 1996-12-06 | 2003-03-19 | Tapic Int Co Ltd | ARTIFICIAL BLOOD VESSEL |
Also Published As
| Publication number | Publication date |
|---|---|
| JPS6158196B2 (enrdf_load_stackoverflow) | 1986-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP3221690B2 (ja) | コラーゲン構造体 | |
| US5028597A (en) | Antithrombogenic materials | |
| US5578073A (en) | Thromboresistant surface treatment for biomaterials | |
| JP4383851B2 (ja) | 多糖類生体材料及びその使用 | |
| JP3784798B2 (ja) | ポリテトラフルオロエチレン製の埋め込み可能なチューブ状プロテーゼ | |
| US5098977A (en) | Methods and compositions for providing articles having improved biocompatability characteristics | |
| EP0230635A2 (en) | Tubular prosthesis having a composite structure | |
| JPS6145765A (ja) | 血管補綴物及びその製造方法 | |
| JPH03254752A (ja) | 人工血管及びその製造方法 | |
| US4833200A (en) | Antithrombogenic medical material and method of preparing same | |
| WO1992009312A1 (fr) | Materiau pour implants | |
| Bruck | Interactions of synthetic and natural surfaces with blood in the physiological environment | |
| JPH0611305B2 (ja) | 抗血栓性材料の製造方法 | |
| EP0781089B1 (en) | Thromboresistant surface treatment for biomaterials | |
| WO1996008149A9 (en) | Thromboresistant surface treatment for biomaterials | |
| Sipehia et al. | Enhanced albumin binding to polypropylene beads via anhydrous ammonia gaseous plasma | |
| JPS60190966A (ja) | 抗血栓性材料 | |
| US5017670A (en) | Methods and compositions for providing articles having improved biocompatibility characteristics | |
| JPS6344383B2 (enrdf_load_stackoverflow) | ||
| Bruck | Physicochemical aspects of the blood compatibility of polymeric surfaces | |
| JPS61263448A (ja) | 血管補綴物 | |
| CA1299937C (en) | Antithrombogenic material | |
| JP3687995B2 (ja) | 人工血管及びその製造方法 | |
| EP0282091A2 (en) | Medical device with heparin slow-release | |
| Wilson | Hemocompatible polymers: preparation and properties |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |